VC  ProQuest Investments

http://www.proquestvc.com





     Office Locations:

2430 Vanderbilt Beach Road, #108 - 190
Naples, FL 34109
Phone: 609-919-3560
Fax: 609-919-3570

 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 1998, ProQuest Investments is a healthcare venture capital firm with over 70 portfolio companies and approximately $900 million under management. At the end of 2006, ProQuest Investments closed its fourth fund of $425 million. The firm has eleven deal professionals working out of its headquarters in Princeton and additional offices in San Diego and Montreal. ProQuest invests in healthcare companies seeking seed to late-stage financing including biopharmaceutical, enabling technology, medical device, and service companies. As a result of investing across a diversity of sectors and stages, the firm's average investment ranges from $250,000 to $25,000,000. ProQuest seeks breakthrough technologies and products that have the potential to revolutionize drug discovery, patient treatment, and healthcare delivery.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Alain Schreiber M.D. Partner
    Jay Moorin Partner
    Karen Hong Ph.D. Partner
    Pasquale (Pat) DeAngelis CFO and Administrative Partner
    Stuart Holden M.D. Chairman

     

    Portfolio companies include:


      Achillion Pharmaceuticals
        web link


      ActivX Biosciences
        web link


      Aerovance
        web link


      Affymax
        web link


      Agile Therapeutics
        web link


      Avanir Pharmaceuticals
        web link


      Biosyntech
        web link


      Cervelo Pharmaceuticals
        web link


      Clarus Therapeutics
        web link


      Clovis Oncology
        web link


      Concentric Medical
        web link


      Eagle Pharmaceutical
        web link


      Excaliard Pharmaceuticals
        web link


      Gemin X Biotechnologies
        web link


      Genta
        web link


      Gloucester Pharmaceuticals
        web link


      Guava Technologies
        web link


      Immune Design
        web link


      Keryx Biopharmaceuticals
        web link


      LEAD Therapeutics
        web link


      Mast Therapeutics
        web link


      Mersana Therapeutics
        web link


      MethylGene
        web link


      Mevion Medical Systems
        web link


      NovaDel Pharma
        web link


      Optimer Pharmaceuticals
        web link


      Orthocon
        web link


      Palkion
        web link


      Pharmacyclics
        web link


      Predictive
        web link


      Revision
        web link


      ReVision Optics
        web link


      Rigel Pharmaceuticals
        web link


      Salmedix
        web link


      SomaLogic
        web link


      Sopherion Therapeutics
        web link


      TeLoRmedix
        web link


      Threshold Pharmaceuticals
        web link


      Tragara Pharmaceuticals
        web link


      Transcept
        web link


      US Bioscience
        web link


      Ziopharm Oncology
        web link


      Zosano Pharma
        web link


     

    Recent News:


      There is no recent news for ProQuest Investments.